- Home
- FORTY vs SLNO Comparison
FORTY vs SLNO Comparison
Compare FORTY & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FORTY | SLNO |
|---|---|---|
| Founded | 1985 | 1999 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 1998 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FORTY | SLNO |
|---|---|---|
| Price | $128.20 | $39.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $108.00 |
| AVG Volume (30 Days) | 346.0 | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | ★ 1.36% | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $1,450,788.00 |
| Revenue This Year | N/A | $155.44 |
| Revenue Next Year | N/A | $57.99 |
| P/E Ratio | ★ $36.65 | $98.67 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $82.74 | $32.63 |
| 52 Week High | $190.56 | $89.12 |
Technical Indicators
Market Signals| Indicator | FORTY | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 48.10 |
| Support Level | $87.16 | $38.17 |
| Resistance Level | $137.20 | $44.60 |
| Average True Range (ATR) | 2.79 | 2.28 |
| MACD | -3.70 | 0.20 |
| Stochastic Oscillator | 24.00 | 75.19 |
Price Performance
Historical ComparisonAbout FORTY Formula Systems (1985) Ltd.
Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources, Michpal, ZAP Group, and Others. The majority of the company's revenue comes from Israel.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.